Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban in DVT Prevention in Colorectal Cancer
IRCT20250204064643N1Phase 3Completed
- Sponsor
- Lorestan University of Medical Sciences
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of apixaban in colorectal cancer (CRC) and deep vein thrombosis (DVT), sponsored by Lorestan University of Medical Sciences. Started Aug 2025; status: completed.
02
Drugs
apixaban
03
Conditions
colorectal cancer (CRC)deep vein thrombosis (DVT)
Beyond the preview
Go deeper on IRCT20250204064643N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250204064643N1.